Physician

Internal Medicine

Gary Blick is an expert in the field of Internal Medicine. He went to University of Miami Miller School of Medicine. University of Miami Miller School of Medicine has a rank of 45 in research and a 0 in primary care Gary Blick is a published doctor. He published 22 publications, including: 'Passive immunotherapy in advanced HIV infection and therapeutic plasmapheresis in asymptomatic HIV-positive individuals: a four-year clinical experience.' He accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
• Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
• 12-month observation of Testosterone replacement effectiveness in a general population of men.
• Patient monitoring and follow-up in lentiviral clinical trials.
• Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for Hepatitis C in patients co-infected with HIV-1: a randomized trial.
• Safety and efficacy of ombitasvir - 450/r and dasabuvir and ribavirin in HCV/HIV-1 co-infected patients receiving atazanavir or raltegravir ART regimens.
• The effect of Testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS).
• Effect of 12 months of Testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS).
• Improved Sexual Function with Testosterone Replacement Therapy in Hypogonadal Men: Real-World Data from the Testim Registry in the United States (TRiUS).
• Changes in prostate specific antigen in hypogonadal men after 12 months of Testosterone replacement therapy: support for the prostate saturation theory.
• Baseline Data From the TRiUS Registry: Symptoms and Comorbidities of Testosterone Deficiency.
• Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trial.
• Pharmacokinetics, safety, and efficacy of tipranavir boosted with ritonavir alone or in combination with other boosted protease inhibitors as part of optimized combina...
• Combined tipranavir and enfuvirtide use associated with higher plasma tipranavir concentrations but not with increased hepatotoxicity: sub-analysis from RESIST.
• Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis.
• The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain fo...
• Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency.
• Passive immunotherapy in advanced HIV infection and therapeutic plasmapheresis in asymptomatic HIV-positive individuals: a four-year clinical experience.
• Successful resolution of progressive multifocal leukoencephalopathy after combination therapy with cidofovir and cytosine arabinoside.
• Successful use of cidofovir in treating AIDS-related cytomegalovirus retinitis, encephalitis, and esophagitis.
• Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.

Schools

---

• University Of Miami School Of Medicine

• University Of Miami Hospital and Clinic

• Greenwich Hospital Association

• Yale University

• Clark University

• American Academy Of Hiv Medicine Specialist

Procedures Preformed

---

• EKG (Electrocardiogram, ECG)
• Immunization
• IV Therapy
• Pap Smear
• View All

Conditions Treated

---

• AIDS
• Diabetes
• Hepatitis B
• Hepatitis C
• View All

Doctors Specialties

---

• Infectious Disease Medicine
• Internal Medicine

Accepted Insurances

---

Education

---

• Jackson Memorial Hospital - Jackson Health System
• University of Miami Miller School of Medicine

Drug Facts

---

NPI NUMBER		1598837957
NPPES Provider LastName		BLICK
NPPES Provider FirstName		GARY
NPPES Provider ZIPCode		068504008
NPPES Provider State		CT
Specialty Description		Internal Medicine
Total Claim Count		3132.0
Distinct Opioid Count		3.0
Opioid Claim Count		46.0
Percent Opioid Claims		1.47

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1598837957
Last Name Of The Provider	BLICK
First Name Of The Provider	GARY
View All

Similar Doctors

---

	Dr. Janet W. Karpiak, MD This Doctor is OpenDoctor Recommended.
	Dr. Eunice Y. Kang, MD This Doctor is OpenDoctor Recommended.
	Dr. Mohamed Y. Ahmed, MD
	Dr. Raman Gill-Meyer, MD
	Dr. Ellen Kulaga, MD This Doctor is OpenDoctor Recommended.
	Dr. Madison A. Leitch, MD
	Dr. Qaayam Pabani, MD
	Dr. Mark Kulaga, MD This Doctor is OpenDoctor Recommended.
	Dr. Dennis G. Huskins, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph Cleary, MD This Doctor is OpenDoctor Recommended.
	Dr. Susan Herson, MD
	Dr. Negar Chooback, MD This Doctor is OpenDoctor Recommended.
	Dr. Tuong-Vi Phan, MD
	Dr. Arthur Yee, MD This Doctor is OpenDoctor Recommended.
	Dr. Andrea Shahum, MD This Doctor is OpenDoctor Recommended.
	Dr. Paolo A. Pino, DO This Doctor is OpenDoctor Recommended.
	Dr. Blaine E. Messing, MD This Doctor is OpenDoctor Recommended.
	Dr. Sushma Ramprasad, MD
	Thilinie D. Bandaranayake, MB BS This Doctor is OpenDoctor Recommended.
	Dr. Franco A. Falcone, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog